Population Health Sciences

While the peak of the COVID-19 pandemic seems to have passed, the effects of post-COVID conditions on public health remain. A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment. 

Financial disruption as a result of pandemic containment policies in the United States adversely influenced children’s mental health.

Weaknesses in the United States laboratory system, which were illuminated during the COVID-19 pandemic, underscore a need for policy changes to improve the country’s infectious disease response.

Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis.

The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms.

Individuals who were already pregnant at the beginning of the COVID-19 pandemic had a 50 percent lower exposure to...

A Medicare system that is meant to assess and incentivize healthcare quality with pay adjustments may not be working as intended, according to a study from researchers at Weill Cornell Medicine.

The Medicaid program allocates nearly $20 billion a year in subsidies to support safety-net hospitals and other health care providers that serve low-income patients. 

Weill Cornell Medicine has been awarded a five-year, $8.1 million grant from the National Institutes of Health (NIH) to support economic analysis, simulation modeling and other research approaches to help stem the national opioid epidemic. 

Dr. Jay Varma, a professor of population health sciences at Weill Cornell Medicine, has received a six-month, $1 million grant from the Bill & Melinda Gates Foundation to assess how countries around the world have been monitoring and reporting COVID-19 infections and outcomes during the pandemic.

By linking a national vascular registry with medical data records in Medicare claims for patients who underwent endovascular abdominal aortic aneurysm repair, researchers were able to identify which devices posed the most risk for reintervention.

Six Weill Cornell Medicine postdoctoral associates, instructors and junior faculty seeking to pursue independent research careers have received 2022 JumpStart Career Development awards.

A Weill Cornell Medicine-led database of more than 15 million patients has received close to $8 million in renewed funding from the Patient-Centered Outcomes Research Institute (PCORI) to expand the database and its use for health research for the next three years.

A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 omicron variant.

Adult vaccination rates and social determinants of health—or the social and economic conditions in which families live and work—have played an important role in children’s mental health during the pandemic, according to a new study led by Weill Cornell Medicine investigators.

The COVID-19 pandemic revealed vast disparities in how the virus impacted people of color, with inequalities in exposure and treatment that persist two years later, said New York State Health Commissioner Dr. Mary Bassett in her Population Health Sciences Grand Rounds address, hosted virtually on April 20 by Weill Cornell Medicine.

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the esteemed Association of American Physicians (AAP).

Anesthesiology prices jump significantly after medical facilities contract with corporate physician management companies – especially those backed by private equity firms – and threaten to hike patient costs, according to new research by Weill Cornell Medicine and Columbia University Mailman School of Public Health investigators. 

Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.

While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.